Royal Sussex County Hospital First in the UK to Enroll a Patient in the Gore REDUCE Clinical Study for the Indication of Patent Foramen Ovale (PFO) Closure

01 November 2011 - International study to demonstrate safety, effectiveness of GORE® HELEX® Septal Occluder for PFO closure in patients with a history of cryptogenic stroke
Gore Acquires Intellectual Property of NMT Medical, Inc.

19 October 2011 - CLOSURE I Trial Data May Create Better Clinical Understanding of Patent Foramen Ovale (PFO) in Stroke Patients
Clinical Investigators Address Confusion Over Study of Patent Foramen Ovale (PFO) in Stroke Patients

13 December 2010 - W. L. Gore & Associates today released the following statement from the Gore REDUCE Clinical Study Principal Investigators on behalf of the Gore REDUCE Clinical Study Steering Committee in response to the recent CLOSURE I results presentation.
Gore Reaffirms Commitment to Stroke Study, Launches Online Resource

15 November 2010 - Cardiology and Neurology Investigators Support Continued Study of Patent Foramen Ovale (PFO)
Gore Provides Update on Patent Foramen Ovale (PFO) Stroke Study

08 July 2010 - Gore Reaffirms Commitment to Multi-National, Randomized Study on PFO Closure in Stroke Patients using GORE® HELEX Septal Occluder Versus Medical Management